GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Mar 16, 2023 · 10-K · 75 days after period end · 0001818331-23-000024
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|
| Revenue | $61.35M | $57.80M | $63.96M |
| Net Income | -$308.76M | -$40.19M | -$125.68M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 16, 2023 · 75 d after period end
